Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Transcompartmental inflammatory responses in humans: IV versus endobronchial administration of endotoxin*

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Clinical Examination for the Prediction of Mortality in the Critically Ill: The Simple Intensive Care Studies-I

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Luxury Perfusion in Patients With Sepsis?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Validation and Clinical Evaluation of a Method for Double-Blinded Blood Pressure Target Investigation in Intensive Care Medicine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Lung Ultrasound in the Assessment of Pulmonary Complications After Lung Transplantation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Point-of-care ultrasound for general practitioners: a systematic needs assessment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Fatal pneumococcus meningitis in a child with complement factor ficolin-3 deficiency

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Vis graf over relationer

OBJECTIVES: Transcompartmental signaling during early inflammation may lead to propagation of disease to other organs. The time course and the mechanisms involved are still poorly understood. We aimed at comparing acute transcompartmental inflammatory responses in humans following lipopolysaccharide-induced pulmonary and systemic inflammation.

DESIGN: Randomized, double-blind, placebo-controlled, crossover study.

SETTING ICU SUBJECTS: Healthy male volunteers.

INTERVENTIONS: Fifteen volunteers (mean age, 23; SD, 2 yr) received Escherichia coli endotoxin (lipopolysaccharide, 4 ng/kg) IV or endobronchially on two different study days. Groups were evaluated by bronchoalveolar lavage at baseline (0 hr) and 2, 4, 6, 8, or 24 hours postchallenge. Cardiorespiratory variables were continuously recorded throughout the study day, and plasma and bronchoalveolar lavage fluid markers of inflammation were measured.

MEASUREMENTS AND MAIN RESULTS: IV endotoxin elicited a systemic inflammatory response with a time-dependent increase and peak in tumor necrosis factor-α, interleukin-6, and leukocyte counts (all p < 0.001). Furthermore, a delayed (6-8 hr) increase in bronchoalveolar lavage fluid interleukin-6 concentration (p < 0.001) and alveolar leukocyte count (p = 0.03) and a minor increase in bronchoalveolar lavage fluid tumor necrosis factor-α were observed (p = 0.06). Endobronchial endotoxin was followed by progressive alveolar neutrocytosis and increased bronchoalveolar lavage fluid tumor necrosis factor-α, interleukin-6, and albumin (all p < 0.001); a systemic inflammatory response was observed after 2-4 hours, with no change in plasma tumor necrosis factor-α.

CONCLUSIONS: Acute lung or systemic inflammation in humans is followed by a transcompartmental proinflammatory response, the degree and differential kinetics of which suggests that the propagation of inflammation may depend on the primary site of injury.

OriginalsprogEngelsk
TidsskriftCritical Care Medicine
Vol/bind42
Udgave nummer7
Sider (fra-til)1658-65
Antal sider8
ISSN0090-3493
DOI
StatusUdgivet - jul. 2014

ID: 44729025